[Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
Bernengo
M G
MG
Doveil
G C
GC
Appino
A
A
Sertoli
M R
MR
Ardizzoni
A
A
Vidili
M G
MG
D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000628:therapy*; D011994:Recombinant Proteins; D012074:Remission Induction; D012878:Skin Neoplasms / Q000628:therapy*
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
Ruolo dell'interferon alfa-2 nel melanoma. Risultati di uno studio in fase II su 27 pazienti.